Nephros NEPH
NASDAQ NEPH
$3.71 +0.00 (+0.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nephros (NEPH) Return on Equity [ROE] (2011 - 2026)

Updated

Nephros (NEPH) reported Return on Equity [ROE] of 15.22% for Q2 2026, up 1.01 percentage points from 14.21% a year earlier and up 7.90 percentage points from the prior quarter.

Analysis

Nephros (NEPH) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Nephros posted Return on Equity [ROE] of 12.71%, up 11.84 percentage points from FY2024.

  • Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +51.62 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at 0.87% in FY2024 (+19.15 pp), -18.27% in FY2023 (+41.87 pp), -60.14% in FY2022 (-34.64 pp) and -25.51% in FY2021 (+13.41 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -76.98% in Q4 2022 and a high of 15.26% in Q3 2025.
  • Year over year, Return on Equity [ROE] gained in seven of the last eight quarters, with an average year-over-year change of +15.26 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2023 (a gain of 58.43 percentage points); the low point was Q4 2022 (a drop of 51.27 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 7.32% (Q1 2026), 11.82% (Q4 2025) and 15.26% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Nephros 40.29 Mn 21.01 Mn 4.03 Mn 15.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.22%
Mar 31, 2026 7.32%
Dec 31, 2025 11.82%
Sep 30, 2025 15.26%
Jun 30, 2025 14.21%
Mar 31, 2025 9.13%
Dec 31, 2024 1.06%
Sep 30, 2024 -11.54%
Jun 30, 2024 -16.07%
Mar 31, 2024 -17.39%
Dec 31, 2023 -18.55%
Sep 30, 2023 -20.48%
Jun 30, 2023 -54.03%
Mar 31, 2023 -61.27%
Dec 31, 2022 -76.98%
Sep 30, 2022 -66.18%
Jun 30, 2022 -41.02%
Mar 31, 2022 -37.63%
Dec 31, 2021 -25.71%
Sep 30, 2021 -23.46%
API Access

Nephros Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NEPH&period=max&api_key=YOUR_API_KEY